Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
about
Role of sphingolipids in senescence: implication in aging and age-related diseasesLifetime cognition and late midlife blood metabolites: findings from a British birth cohortPopulation Health Solutions for Assessing Cognitive Impairment in Geriatric PatientsHigh-Throughput Direct Mass Spectrometry-Based Metabolomics to Characterize Metabolite Fingerprints Associated with Alzheimer's Disease Pathogenesis
P2860
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Brain and blood metabolite sig ...... A targeted metabolomics study.
@en
Brain and blood metabolite sig ...... A targeted metabolomics study.
@nl
type
label
Brain and blood metabolite sig ...... A targeted metabolomics study.
@en
Brain and blood metabolite sig ...... A targeted metabolomics study.
@nl
prefLabel
Brain and blood metabolite sig ...... A targeted metabolomics study.
@en
Brain and blood metabolite sig ...... A targeted metabolomics study.
@nl
P2093
P2860
P50
P1433
P1476
Brain and blood metabolite sig ...... A targeted metabolomics study
@en
P2093
Gabi Kastenmueller
Madhav Thambisetty
Olga Pletnikova
P Murali Doraiswamy
Ramon Casanova
Richard O'Brien
Sudhir Varma
P2860
P304
P356
10.1371/JOURNAL.PMED.1002482
P407
P50
P577
2018-01-25T00:00:00Z